Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Other financing activities (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Other financing activities for 15 consecutive years, with -$5.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Other financing activities changed N/A to -$5.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$90000.0, a 105.93% decrease, with the full-year FY2025 number at -$90000.0, down 105.93% from a year prior.
  • Other financing activities was -$5.1 million for Q4 2025 at Acadia Healthcare Company, up from -$13.6 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $18.6 million in Q2 2025 to a low of -$13.6 million in Q3 2025.
  • A 5-year average of $1.4 million and a median of $1.3 million in 2021 define the central range for Other financing activities.
  • Peak YoY movement for Other financing activities: tumbled 214.51% in 2023, then skyrocketed 2545.67% in 2025.
  • Acadia Healthcare Company's Other financing activities stood at $6.2 million in 2021, then crashed by 64.57% to $2.2 million in 2022, then crashed by 214.51% to -$2.5 million in 2023, then surged by 69.53% to -$762000.0 in 2024, then plummeted by 567.98% to -$5.1 million in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Other financing activities are -$5.1 million (Q4 2025), -$13.6 million (Q3 2025), and $18.6 million (Q2 2025).